Bigfoot Biomedical Inc.
Automated insulin delivery for type 1 diabetes
This article was originally published in Start Up
Each of the four founders of Silicon Valley-based Bigfoot Biomedical Inc. has a spouse or child with type 1 diabetes. That personal connection to the disease drove them to develop an integrated management system to streamline the delivery of the correct amount of insulin and reduce adverse outcomes for the disease.